News
September 2024
September 2024
Addinex chosen to participate in Memorial Sloan Kettering Cancer Center’s inaugural Innovation Hub Challenge, focused on Decentralized Clinical Trials. Addinex will collaborate closely with MSK over the next three months to develop a targeted remote medication management system for monitoring cancer drug usage in remote clinical trials.
January 2024
Addinex was one of only four companies accepted into the Mount Sinai Innovation Partners Elementa Labs program. Addinex's team is working with the Chief of General Surgery and the Chief Pharmacy Officer on several commercialization projects.
May 2023
Yale School of Medicine survey of 146 psychiatrists with experience in addiction medicine showed 91% of doctors expressing that they were encouraged by the availability of the Addinex system, 75% deeming the system very or extremely useful, and 65% stating that they would prescribe it with another 30% needing more information before they would do so.
March 2023
Columbia University Medical Center launches second Addinex study, "Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and to Reduce Refills After Cancer-Related Surgery."
September 2022
Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing.
July 2022
May 2022